Description of Protocol to Evaluate MN-001'S (tipelukast) Efficacy, Safety and Tolerability in Subjects with Idiopathic Pulmonary Fibrosis
- Bascom, R. (Speaker)
- K. Hitz (Speaker)
- Anne E F Dimmock (Speaker)
- M. Makhay (Speaker)
- J. Dojillo (Speaker)
- K. Matsuda (Speaker)
Activity: Talk types › Invited talk